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VCAM-1/41 Integrin Interaction Is Crucial for Prompt Recruitment
of Immune T Cells into the Brain during the Early Stage of
Reactivation of Chronic Infection with Toxoplasma gondii To Prevent
Toxoplasmic Encephalitis
Qila Sa,a Eri Ochiai,a* Tomoko Sengoku,b Melinda E. Wilson,b Morgan Brogli,a Stephen Crutcher,a Sara A. Michie,c Baohui Xu,c
Laura Payne,d Xisheng Wang,d* Yasuhiro Suzukia,d
Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, Kentucky, USAa; Department of Physiology,
University of Kentucky College of Medicine, Lexington, Kentucky, USAb; Department of Pathology, Stanford University School of Medicine, Stanford, California, USAc;
Center for Molecular Medicine and Infectious Diseases, Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine,
Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USAd
Reactivation of chronic infection with Toxoplasma gondii can cause life-threatening toxoplasmic encephalitis in immunocom-
promised individuals. We examined the role of VCAM-1/41 integrin interaction in T cell recruitment to prevent reactivation
of the infection in the brain. SCID mice were infected and treated with sulfadiazine to establish a chronic infection. VCAM-1 and
ICAM-1 were the endothelial adhesion molecules detected on cerebral vessels of the infected SCID and wild-type animals. Im-
mune T cells from infected wild-type mice were treated with anti-4 integrin or control antibodies and transferred into infected
SCID or nude mice, and the animals received the same antibody every other day. Three days later, sulfadiazine was discontinued
to initiate reactivation of infection. Expression of mRNAs for CD3, CD4, CD8, gamma interferon (IFN-), and inducible ni-
tric oxide synthase (NOS2) (an effector molecule to inhibit T. gondii growth) and the numbers of CD4 and CD8 T cells in the
brain were significantly less in mice treated with anti-4 integrin antibody than in those treated with control antibody at 3 days
after sulfadiazine discontinuation. At 6 days after sulfadiazine discontinuation, cerebral tachyzoite-specific SAG1 mRNA levels
and numbers of inflammatory foci associated with tachyzoites were markedly greater in anti-4 integrin antibody-treated than
in control antibody-treated animals, even though IFN- and NOS2 mRNA levels were higher in the former than in the latter.
These results indicate that VCAM-1/41 integrin interaction is crucial for prompt recruitment of immune T cells and induc-
tion of IFN--mediated protective immune responses during the early stage of reactivation of chronic T. gondii infection to con-
trol tachyzoite growth.
Toxoplasma gondii, an obligate intracellular protozoan parasite,is an important food-borne pathogen in humans. Acute infec-
tion is characterized by proliferation of tachyzoites in a variety of
cells throughout the body and can cause various diseases, includ-
ing lymphadenitis and congenital infection of fetuses (1). Gamma
interferon (IFN-)-dependent, cell-mediated immune responses
(2–4) and, to a lesser degree, humoral immunity (5–7) can sup-
press proliferation of tachyzoites, but the parasite establishes a
chronic infection by forming tissue cysts, primarily in the brain.
Chronic infection with T. gondii is one of the most common par-
asitic infections in humans (8, 9). It is estimated that 500 million
to 2 billion people worldwide are chronically infected with the
parasite (8, 10). The importance of immune responses in main-
taining the latency of the chronic infection is clearly evident in the
development of life-threatening toxoplasmic encephalitis (TE),
caused by reactivation of the chronic infection in immunocom-
promised individuals, such as those with AIDS and organ trans-
plants (11, 12). However, the mechanisms by which the immune
system maintains the latency of chronic infection with T. gondii in
the brain and prevents TE still need to be elucidated.
T. gondii has three predominant genotypes (I, II, and III), and
infection with all the genotypes occurs in humans (13–15). How-
ever, type II is predominant in the strains isolated from patients
with TE in North America and Europe (16, 17). Because TE mostly
occurs due to reactivation of chronic infection with the parasite,
mouse strains that can establish a latent, chronic infection with
type II strains of the parasite appear to be an ideal animal model to
analyze the mechanisms by which the immune system maintains
the latency of the chronic infection in the brain. In this regard,
resistance to chronic infection with type II T. gondii is under ge-
netic control in mice, and strains of inbred mice can be generally
divided into two groups. Strains with the H-2b (e.g., C57BL/6) or
H-2k (e.g., CBA/Ca) haplotype are susceptible and develop pro-
gressive and ultimately fatal TE without immunosuppressive
treatment (18, 19). In contrast, strains with the H-2d haplotype
(e.g., BALB/c) are resistant and establish a latent, chronic infec-
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tion (18, 19), as do immunocompetent humans. Therefore,
BALB/c mice appear to provide an excellent model to analyze how
the immune system functions to maintain the latency of chronic
type II T. gondii infection in the brain.
Infecting BALB/c-background SCID or athymic nude mice
with a type II (ME49) strain and treating them with sulfadiazine
enables them to establish a chronic infection in their brains (20,
21). Discontinuation of sulfadiazine treatment induces reactiva-
tion of the chronic infection in the brain in these immunodeficient
mice, and adoptive transfer of immune T cells from infected wild-
type BALB/c mice into these animals can prevent the reactivation
of infection (20, 22, 23). Therefore, this T cell transfer system in
BALB/c-background SCID and nude mice provides an excellent
model to analyze the mechanisms by which the immune system
prevents reactivation of the infection in the brain and develop-
ment of TE.
The blood-brain barrier prevents most intravascular leuko-
cytes from entering the parenchyma of the normal brain (24).
However, leukocytes are able to migrate from blood vessels into
the brain when infection, ischemia, or an autoimmune disease,
such as multiple sclerosis, occurs. This migration is mediated, in
part, by endothelial adhesion and activation molecules that are
found in injured brain but not in normal brain (24). In the present
study, we utilized the SCID and nude mouse model of reactivation
of cerebral T. gondii infection and analyzed vascular endothelial
adhesion molecules important for T cell recruitment into the
brain and prevention of reactivation of the infection. We found
that interactions between VCAM-1 expressed on cerebrovascular
endothelial cells and 41 integrin expressed on the surfaces of
immune T cells are crucial for recruiting the T cells into the brain
and inducing IFN--mediated protective immunity during the
early stage of reactivation of cerebral infection with T. gondii. Such
prompt induction of T cell migration and IFN--mediated im-
mune responses was associated with effective control of tachyzoite
proliferation and prevention of TE.
MATERIALS AND METHODS
Mice. Female BALB/c and BALB/c-background SCID mice were obtained
from the Jackson Laboratories (Bar Harbor, ME). Female BALB/c-back-
ground athymic nude mice were from the Jackson Laboratories or Tac-
onic (Germantown, NY). Female Swiss-Webster mice were from Taconic.
All the mice were housed under specific-pathogen-free conditions. There
were 3 to 6 mice in each experimental group.
Infection with T. gondii and reactivation of cerebral infection. Cysts
of the ME49 strain of T. gondii were obtained from brains of chronically
infected Swiss-Webster mice (25). The mice were euthanized by asphyx-
iation with CO2, and their brains were removed and triturated in phos-
phate-buffered saline (PBS) (pH 7.2). An aliquot of the brain suspension
was examined microscopically for the number of cysts, and after appro-
priate dilution in PBS, BALB/c, SCID, and nude mice were infected with
10 cysts orally by gavage (20). SCID and nude mice received sulfadiazine-
supplemented drinking water (400 mg/liter) beginning 7 or 8 days after
infection for 3 to 4 weeks to control the proliferation of tachyzoites and
establish a chronic infection in their brains (20, 21). Reactivation of cere-
bral infection with T. gondii was induced in the SCID and nude mice by
discontinuing sulfadiazine treatment (20, 22, 23). In one experiment, one
group of wild-type BALB/c mice received sulfadiazine for 11 days begin-
ning 14 days after infection to examine whether sulfadiazine treatment
could affect the expression of cerebrovascular endothelial adhesion mol-
ecules during the infection. Mouse care and experimental procedures
were performed in accordance with established institutional guidance
and approved protocols from the Institutional Animal Care and Use
Committee.
Immunohistochemistry for vascular adhesion molecules. Brains
from BALB/c and SCID mice were removed 25 days after infection, which
is the time that the SCID mice were receiving sulfadiazine; bisected along
the median sagittal plane; and snap-frozen in OCT compound (Sakura
Finetek, Torrance, CA). Acetone-fixed frozen sections were stained as
previously described with monoclonal antibodies (MAbs) against
ICAM-1 (clone YN1/1.7; ATCC, Manassas, VA, and Abcam, Cambridge,
MA), VCAM-1 (MK-2.7; ATCC and Abcam), E-selectin (10E9.6; BD
PharMingen, San Diego, CA), P-selectin (RB40; ATCC), MAdCAM-1
(MECA-367; provided by E. Butcher, Stanford, CA), PNAd (MECA-79;
provided by E. Butcher), and irrelevant negative-control antigens (26).
Briefly, the sections were sequentially incubated with rat primary anti-
body, biotin-conjugated anti-rat IgG, or anti-rat IgM; peroxidase-strepta-
vidin; diaminobenzidine/hydrogen peroxide; and methylene blue or he-
matoxylin counterstain. There were two washes with PBS between the
steps. Three or more sections, at least 200 m apart, were stained for each
adhesion molecule in each brain. The slides were examined by light mi-
croscopy. The numbers of vessels expressing VCAM-1 or ICAM-1 per
mm2 of brain area were determined by image analysis, as described pre-
viously (27).
Flow cytometry to detect expression of 41 integrin on CD4 and
CD8 immune T cells from BALB/c mice chronically infected with T.
gondii. Spleen cells were obtained from chronically infected BALB/c mice
and suspended in Hanks’ balanced salt solution (HBSS) (HyClone, Logan,
UT) containing 2% fetal bovine serum (FBS) (Sigma, St. Louis, MO).
After depletion of red blood cells with 160 mM NH4Cl (pH 7.2), the cells
were incubated on ice for 10 min with a predetermined optimal amount of
anti-FcII/III receptor MAb (clone 2.4G2). The cells were then incubated
for 30 min with an allophycocyanin (APC)-conjugated MAb to CD4
(clone RM4-5) or an APC-conjugated MAb to CD8 (clone 53-6.7), in
combination with phycoerythrin (PE)-conjugated MAb to 4 integrin
(clone 9C10), fluorescein isothiocyanate (FITC)-conjugated MAb to 1
integrin (clone Ha2/5), and PE-Cy5-conjugated MAb to CD44 (clone
IM7). Isotype control antibodies were used as negative controls. All but
FITC-hamster IgM() (BioLegend, San Diego, CA) were purchased from
BD Biosciences (Mountain View, CA). Cells were analyzed on a FAC-
SCalibur using CellQuest software (BD Biosciences). At least 20,000 cells
in the gated area for lymphocytes were analyzed.
Adoptive transfer of T cells and blocking of T cell homing by MAb
against 4 integrin. Spleen cells were obtained from chronically infected
BALB/c mice and suspended in HBSS containing 2% FBS. Immune T cells
were purified by treating the immune spleen cells with magnetic-bead-
conjugated anti-CD4 and anti-CD8 MAb (Miltenyi Biotech, Sunnyvale,
CA) for magnetic cell sorting (MACS), as previously described (20–23).
The purity of the MACS-purified T cells was 95%. Immune T cells were
treated with 10 g/ml of anti-4 integrin MAb (PS/2, grown from a hy-
bridoma obtained from ATCC [28]) or a control MAb (9B5 [28] [anti-
human CD44] or RTK4530 [anti-trinitrophenol-KLH] [BioLegend]) on
ice for 10 min (28). The cells (0.9  107 to 1.5  107) were transferred into
infected and sulfadiazine-treated SCID or nude mice at 4 weeks after
infection. Thereafter, the animals received the MAb (200 or 250 g in 0.2
ml PBS) intraperitoneally every other day. Sulfadiazine treatment was
discontinued 3 days after the cell transfer to initiate reactivation of T.
gondii infection.
Immunohistochemistry for T cells that infiltrated into the brain af-
ter T cell transfer. SCID mice were infected, treated with sulfadiazine, and
received immune T cells in combination with treatment with anti-4
integrin MAb or isotype control MAbs as described above. At 3 days after
discontinuation of sulfadiazine treatment, their brains were snap-frozen
in OCT compound in the same manner as described in “Immunohisto-
chemistry for vascular adhesion molecules” above. Sections were stained
with anti-CD3 (17A2; BioLegend) or isotype control (RTK4530) diluted in
PBS containing 2.5% normal donkey serum (Jackson ImmunoResearch,
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West Grove, PA) in the same manner as described for staining for vascular
adhesion molecules with hematoxylin counterstain.
Immunohistochemical staining of T. gondii. The brains of infected
nude mice that had received immune T cells in combination with treat-
ment with anti-4 integrin MAb or isotype control MAbs were obtained 6
days after discontinuation of sulfadiazine treatment and fixed with 10%
formalin, 70% ethanol, and 5% acetic acid. Staining for T. gondii on the
histological sections of the brains was performed as described previously
(29). Briefly, the sections were sequentially incubated with rabbit anti-T.
gondii primary antibody, goat anti-rabbit IgG antibody, peroxidase-rab-
bit anti-peroxidase complex, diaminobenzidine/hydrogen peroxide, and
hematoxylin counterstain. Three sections, at least 50 m apart, were
stained in each brain. In counting parasitophorous vacuoles (PV) con-
taining tachyzoites in inflammatory foci, a photograph of each of the foci
containing large numbers of PV was taken at a high magnification, and the
PV in each focus were counted on a large image or print of the photo-
graph.
Flow cytometry to detect T cells that migrated into the brains of
infected nude mice after T cell transfer. Sulfadiazine treatment of in-
fected nude mice was discontinued 3 days after receiving immune T cells
to initiate reactivation of cerebral infection with T. gondii. Three days after
discontinuation of sulfadiazine treatment, anesthetized animals were per-
fused intracardially with PBS to remove intravascular leukocytes. Mono-
nuclear cells were isolated from brains from each group as described pre-
viously (30). After treating the cells with anti-FcII/III receptor MAb, the
cells were incubated for 30 min with a PE-conjugated MAb to CD4 (clone
RM4-5) or a FITC-conjugated MAb to CD8 (clone 53-6.7) in combina-
tion with peridinin chlorophyll protein (PerCP)-conjugated MAb to
CD3ε (clone 145-2C11). All MAbs were from BD Biosciences. Fluores-
cence-activated cell sorter (FACS) analysis was performed in the same
manner as described for detection of 41 integrin on immune T cells.
Quantification of mRNAs for CD3, CD4, CD8, IFN-, NOS2,
VCAM-1, MAdCAM-1, tachyzoite-specific SAG1, and bradyzoite-spe-
cific BAG1 in the brain. Total RNAs were purified from brains of SCID
and nude mice using RNA Stat-60 (Tel-Test B, Inc., Friendswood, TX),
and 1 g of RNA was treated with DNase I (Invitrogen, Carlsbad, CA) and
reverse transcribed into cDNA using Moloney murine leukemia virus
(MMLV) reverse transcriptase (Invitrogen) according to the manufac-
turer’s instructions (20). To quantify tachyzoites in the mouse brains,
real-time PCR was conducted in triplicate to measure the amounts of
mRNA for tachyzoite-specific SAG1 using TaqMan reagents and the
StepOnePlus real-time PCR system (Applied Biosystems, Foster City,
CA) as described previously (31, 32). mRNA levels of CD3	, CD4, CD8,
IFN-, and BAG1 were also measured with the following primers and
probes: CD3	, AAGCCCCAATTGCAACAAAACT (forward), GGCAGG
TTTGATCTCCGTTCT (reverse), and TCAGTGTAGCAATGATTTC
(probe); CD4, CATCTCTCTTAGGCGCTTGCT (forward), GCGTCTT
CCCTTGAGTGACA (reverse), and CAGCTGTCACAACTCC (probe);
CD8, CCTCGGAGTGGCCGTCTA (forward), GCGCTGATCATTTGT
GAAACTGTTT (reverse), and CCGCACACAGTAAAAG (probe);
IFN-, CATTGAAAGCCTAGAAAGTCTGAATAA (forward), TGGCTC
TGCAGGATTTTCATG (reverse), and TCACCATCCTTTTGCCAGTTC
CTCCAG (probe); BAG1, TCACGTGGAGACCCAGAGT (forward), CT
GGCAAGTCAGCCAAAATAATCAT (reverse), and TTTGCTGTCGAA
CTCC (probe). The IFN- probe was labeled with 6-carboxyfluorescein
(FAM) at the 5= end and TAMRA at the 3= end. All the other probes were
labeled with FAM at the 5= ends and minor groove binder (MGB)-non-
fluorescent quencher (NFQ) at the 3= ends. Mouse -actin was used as an
endogenous control and, the comparative threshold cycle (Ct) method
was applied to analyze the data. Mouse -actin (mouse ACTB; 4352933E),
NOS2 (Mm00440489_g1), VCAM-1 (Mm01320970_m1), and MAd-
CAM-1 (Mm00522088_m1) gene expression kits and all the primers and
probes were from Applied Biosystems.
Statistical analysis. Numerical data are presented as means and stan-
dard errors. Differences between groups were analyzed with one-way
analysis of variance (ANOVA) with a Newman-Keuls posttest or Mann-
Whitney test. A P value of 
0.05 was considered to be significant.
RESULTS
Expression of endothelial adhesion molecules on cerebral ves-
sels of SCID and wild-type BALB/c mice infected with T. gondii.
We previously reported that VCAM-1 and ICAM-1 are the vascu-
lar endothelial adhesion molecules whose expression is upregu-
lated in the brains of BALB/c mice during chronic infection with
T. gondii (33). To examine whether BALB/c-background SCID
mice with chronic infection express the same vascular adhesion
molecules in their brains as infected wild-type mice, the two
strains of mice were infected and the SCID mice received treat-
ment with sulfadiazine from 7 days after infection to control the
proliferation of tachyzoites and establish a chronic infection (20,
21). We stained frozen sections of brains from SCID and wild-type
mice with antibodies against ICAM-1, VCAM-1, E-selectin, P-
selectin, MAdCAM-1, and PNAd 25 days after infection. A few
vessels in the brains of uninfected SCID and wild-type mice ex-
pressed VCAM-1 (1.71  0.41 and 4.51  1.47 vessels/mm2 of
tissue, respectively) (Fig. 1A). Infection with T. gondii caused an
increase in vascular VCAM-1 expression in both strains (P 
 0.05)
(Fig. 1A). The mean number of VCAM-1-expressing vessels in
the brains of infected wild-type mice tended to be slightly
greater than in infected SCID mice, but the difference did not
reach statistical significance (Fig. 1A). Very few vessels in the
brains of uninfected SCID and wild-type mice had detectable
levels of ICAM-1 (Fig. 1B). After T. gondii infection, both strains
had 7- to 30-fold increases in the number of ICAM-1 vessels
(P 
 0.05) (Fig. 1B).
We did not detect expression of E-selectin, P-selectin,
MAdCAM-1, or PNAd on cerebral vessels in infected or uninfected
mice of either strain. Treatment of infected wild-type mice with
sulfadiazine did not alter the expression of vascular adhesion mol-
ecules in their brains (Fig. 1A and B). Examples of staining for
VCAM-1 and ICAM-1 in uninfected and chronically infected
BALB/c mice are shown in Fig. 1C. These results indicate that
ICAM-1 and VCAM-1 are the cerebrovascular endothelial adhe-
sion molecules whose expression is upregulated during chronic
infection with T. gondii in both SCID and wild-type BALB/c mice.
These results strongly suggest that a model using infected, sulfa-
diazine-treated SCID mice and a transfer of immune T cells is
suitable to examine the roles of the cerebrovascular endothelial
adhesion molecules in T cell recruitment into the brain to prevent
reactivation of chronic infection with T. gondii. Our results in T.
gondii infection are different from those observed in mice with
experimental allergic encephalitis and a model of Alzheimer’s dis-
ease, in which P-selectin expression is enhanced (34–36), suggest-
ing that expression of cerebrovascular endothelial adhesion mol-
ecules differs depending on the stimuli present under the specific
conditions.
Importance of 4 integrin for recruiting CD4 and CD8
immune T cells into the brain during the early stage of reactiva-
tion of T. gondii infection. We previously showed that IFN-
plays an important role in recruiting immune T cells into the
brains of T. gondii-infected BALB/c mice and that expression of
endothelial VCAM-1, but not ICAM-1, in their brains is largely
dependent on IFN- (33). Our previous study also showed that
endothelial VCAM-1 is important for migration of carboxyfluo-
rescein succinimidyl ester (CFSE)-labeled immune CD8 T cells
Sa et al.
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into the brains of infected BALB/c mice (33). Therefore, we uti-
lized a reactivation model of T. gondii infection in SCID and nude
mice and examined the role of VCAM-1/41 integrin interac-
tion in recruitment of immune T cells to prevent reactivation of
the infection. In this model, SCID and nude mice were infected
and treated with sulfadiazine to establish a chronic infection in
their brains (20, 22). Discontinuation of sulfadiazine treatment
initiates reactivation of the cerebral infection and results in mor-
tality of the animals within 2 weeks after the initiation of reactiva-
tion of the infection (20, 22). Adoptive transfer of immune T cells
from chronically infected BALB/c mice can prevent the reactiva-
tion of infection and the mortality (20, 22).
FIG 1 VCAM-1 and ICAM-1 are the endothelial adhesion molecules expressed on cerebral vessels in SCID and wild-type BALB/c mice with chronic infection
with T. gondii. SCID and wild-type BALB/c mice were infected with 10 cysts of the ME49 strain orally. The SCID mice were treated with sulfadiazine beginning
7 days after infection. One group of BALB/c mice also received sulfadiazine beginning 14 days after infection. All the mice were sacrificed 25 days after infection.
(A and B) The number of cerebral vessels that expressed VCAM-1 or ICAM-1 was determined by frozen-section immunohistochemistry staining and quanti-
tative image analysis (see Materials and Methods). (C) Examples of VCAM-1 and ICAM-1 staining in the brains of uninfected and chronically infected BALB/c
mice. The arrows indicate representative VCAM-1 and ICAM-1 vessels. (D) Expression of mRNA for VCAM-1 and MAdCAM-1 in the brains of uninfected
and infected SCID mice. The mRNA levels were determined by real-time RT-PCR (see Materials and Methods). *, P 
 0.05; **, P 
 0.01. The error bars indicate
standard errors.
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Infected, sulfadiazine-treated SCID mice received a systemic
transfer of immune T cells purified from the spleens of chronically
infected BALB/c mice in combination with treatment with an-
ti-4 integrin or control MAb at 3 weeks after infection. The an-
ti-4 integrin MAb is known to block 41 integrin/VCAM-1
and 47 integrin/MAdCAM-1 binding (37, 38). However, be-
cause MAdCAM-1 was not detected on intracerebral vessels in the
infected mice in the immunohistochemistry, any inhibitory effect
of the MAb in this mouse model would be on 41/VCAM-1
binding. In order to further confirm that MAdCAM-1 is not ex-
pressed in the brains of infected SCID mice, we performed real-
time reverse transcription (RT)-PCR to measure amounts of
mRNA for VCAM-1 and MAdCAM-1 expressed in the brains of
uninfected and infected SCID mice. The amounts of VCAM-1
mRNA were significantly greater in the brains of infected than
uninfected SCID mice (P 
 0.05) (Fig. 1D). This is in agreement
with the detection of larger numbers of cerebral vessels expressing
this vascular adhesion molecule in the brains of infected than in
those of uninfected animals in the immunohistochemistry shown
in Fig. 1A. In contrast, MAdCAM-1 mRNA levels did not differ
between the brains of uninfected and infected SCID mice (Fig.
1D), and mRNA levels for MAdCAM-1 in the brains of infected
SCID mice were approximately 280 times lower than those for
VCAM-1 in these animals (Fig. 1D). Therefore, the infection
did not stimulate expression of MAdCAM-1 mRNA in their
brains, and the mRNA expression remained at a very low level.
These results are consistent with our observation in immunohis-
tochemistry, in which cerebral vessels expressing MAdCAM-1
were not detected in these animals. These results indicate that
the inhibitory effect of anti-4 integrin MAb on T cell recruit-
ment into the brain in this mouse model is on 41/VCAM-1
binding.
Three days after the transfer of immune T cells into infected
SCID mice in combination with treatment with anti-4 integrin
or control MAb, sulfadiazine treatment was discontinued to ini-
tiate reactivation of the infection in the brain (20, 22, 23). Three
days after discontinuation of sulfadiazine treatment, we examined
the amounts of mRNA for T cell markers (CD3	, CD4, and
CD8) in the brains of the SCID mice. The amounts of mRNAs
for CD3	, CD4, and CD8 were 27.9, 10.5, and 34.1 times less,
respectively, in the brains of mice treated with anti-4 integrin
MAb than in the brains of animals treated with control MAb (P 

0.001) (Fig. 2A). In a control group that did not receive a transfer
of T cells, the amounts of mRNA for these T cell markers in their
brains were close to detectable limits or very low even when de-
tected (Fig. 2A). Immunohistochemistry detecting CD3 T cells
demonstrated the presence of large numbers of T cells in the pa-
renchyma of the brains of SCID mice treated with control MAb
(Fig. 2B, middle), but not in the brains of the animals treated with
anti-4 integrin MAb (Fig. 2B, right). CD3 T cells were also
detectable in association with some cerebral vessels, in addition to
the parenchyma, of the SCID mice treated with control MAb (Fig.
2B, left). We also measured the amounts of mRNA for VCAM-1
expressed in the brains of infected SCID mice on the last day of
sulfadiazine treatment and 3 days after discontinuation of the
treatment. Comparable levels of cerebral VCAM-1 mRNA were
detected before and after initiation of reactivation of cerebral T.
gondii infection (data not shown). These results strongly sug-
gested that VCAM-1/41 integrin interaction is crucial for me-
diating infiltration of both CD4 and CD8 immune T cells into
the brain parenchyma during the early stage of reactivation of
cerebral infection with T. gondii.
To further confirm the importance of 4 integrin in recruit-
ment of immune T cells into the brain during reactivation of in-
fection, we also examined cerebral expression of mRNA for T cell
markers 3 days after discontinuation of sulfadiazine treatment in
infected nude mice that had received immune T cells in combina-
tion with anti-4 integrin or control MAb treatment. Whereas
SCID mice lack both T and B cells, nude mice have B cells. There-
fore, by using nude mice, we were able to examine the mechanisms
of T cell recruitment into the brain to prevent reactivation of
chronic T. gondii infection in the presence of B cells. Consistent
with those observed in the brains of infected SCID mice, the
amounts of mRNA for CD3	, CD4, and CD8 were 3.0, 2.6, and
3.9 times less, respectively, in the brains of the nude mice treated
with anti-4 integrin MAb than in the brains of animals treated
with control MAb (P 
 0.05) (Fig. 3A).
We also performed flow cytometric analyses to examine the
numbers of CD4 and CD8 T cells recruited into the brains of
the infected nude mice after they received immune T cells in com-
bination with treatment with anti-4 integrin or control MAb.
The numbers of mononuclear cells purified from the brains of the
former and the latter groups of mice were 0.93  106 cells/mouse
and 1.24  106 cells/mouse, respectively. The percentages of
CD4 and CD8 T cells in the mononuclear cell preparations
were 14.0  1.15 and 8.83  1.33, respectively, in the mice treated
with anti-4 integrin MAb, and they were14.3  0.81 and 15.5 
2.14, respectively, in those treated with control MAb. Figure 3B
shows the numbers of CD4 and CD8 T cells that had migrated
into the brains of the two groups of mice, calculated from these
numbers. In agreement with the mRNA expression data, CD4
and CD8 T cells detected in the brain were significantly fewer in
nude mice treated with anti-4 MAb than in the brains of animals
treated with control MAb (P 
 0.001) (Fig. 3B). These results
from SCID and nude mice indicate that the binding of lymphocyte
41 integrin to endothelial VCAM-1 on cerebral vessels plays a
crucial role in recruitment of CD4 and CD8 immune T cells
into the brains of mice during the early stage of reactivation of
infection with T. gondii.
Expression of 41 integrin on the CD44high population of
both CD4 and CD8 immune T cells in the spleens of BALB/c
mice chronically infected with T. gondii. We previously demon-
strated that both CD4 and CD8 T cells that infiltrated into the
brains of chronically infected BALB/c mice are a CD44high LFA-
1high CD62Lneg effector/memory T cell population (33). To fur-
ther confirm the importance of VCAM-1/41 integrin interac-
tions in recruiting immune T cells into the brains of chronically
infected SCID and nude mice from the experiments described
above, we examined the expression of 41 integrin on the sur-
faces of the CD44high population of splenic immune T cells of
chronically infected BALB/c mice, which were transferred into
infected recipients. A majority (71 to 79%) of the CD44high pop-
ulations of both CD4 and CD8 immune T cells were positive
for 41 integrin (Fig. 4). Interestingly, large portions (42 to
59%) of these CD44high T cell populations expressed high levels of
this adhesion molecule, indicated as 41 integrinhigh in Fig. 4. As
a comparison, we also examined the expression of 41 integrin
on a CD44low population of splenic immune T cells, which do not
enter the brains of infected mice (33). Many T cells in the CD44low
population were also detected as 41 integrin (Fig. 4), but only
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low percentages (4.6 to 12%) of these T cells expressed high levels
of the adhesion molecule (Fig. 4).
Importance of 4 integrin for inducing IFN--mediated
protective immune responses in the brain during the early stage
of reactivation of T. gondii infection. Because IFN- production
by T cells is required for the prevention of reactivation of T. gondii
infection (29, 33) and because IFN--mediated expression of
NOS2 is important for preventing tachyzoite growth in the brain
(39, 40), we next examined mRNA expression of IFN- and NOS2
in the brains of SCID mice that received immune T cells with
anti-4 integrin or control MAb treatment. Three days after dis-
continuation of sulfadiazine, the amounts of mRNAs for IFN-
and NOS2 detected in the brains of SCID mice treated with an-
ti-4 integrin MAb were 5.7 and 9.2 times less than those in the
brains of animals treated with control MAb (P 
 0.05 and P 

0.01) (Fig. 5A). mRNA levels for both IFN- and NOS2 in control
mice that had not received T cells were very low or close to detect-
able limits (Fig. 5A), indicating that the majority of IFN- and
NOS2 expressed in the brains of animals with the T cell transfer
were from or induced by T cells that had migrated into their
brains. The amounts of mRNA for tachyzoite-specific SAG1 in the
brains of the animals were low and close to detectable limits in
most of the mice at this early stage of reactivation of infection, and
there were no significant differences in their amounts between the
experimental groups (data not shown).
We also compared expression of IFN- and NOS2 in the brains
of nude mice that had received immune T cells in combination
with anti-4 integrin or control MAb treatment. Three days
after discontinuation of sulfadiazine treatment, the amounts of
mRNAs for IFN- and NOS2 were 2.8 and 3.8 times less, respec-
tively, in the brains of anti-4 integrin MAb-treated mice than
those in control MAb-treated animals (P 
 0.05) (Fig. 5B). The
levels of IFN- and NOS2 mRNAs in the brains of the former were
as low as those detected in the brains of control nude mice that had
not received T cells (Fig. 5B). The expression levels of IFN- and
NOS2 in the control animals without T cell transfer (Fig. 5B) were
higher than those in the control SCID mice without T cell transfer
(Fig. 5A). Such differences between the control nude and SCID
FIG 2 Cerebral expression of mRNA for T cell markers (CD3	, CD4, and CD8) (A) and frequency of CD3 T cells in the brain tissue (B) are markedly less
during the early stage of reactivation of T. gondii infection in the brains of SCID mice that received immune T cells with anti-4 integrin MAb treatment than in
those with the cell transfer with control MAb. SCID mice were infected with 10 cysts of the ME49 strain orally and treated with sulfadiazine for 3 weeks beginning
7 days after infection. Groups of animals received immune T cells (1.2  107 cells) pretreated with either anti-4 integrin or control MAb intravenously 4 weeks
after infection. Thereafter, the mice received the MAb (250 g) intraperitoneally every other day. Sulfadiazine treatment was discontinued 3 days after the cell
transfer, and the brains were collected 3 days after discontinuation of sulfadiazine treatment. (A) mRNA levels for the T cell markers were measured by real-time
RT-PCR. **, P 
 0.01; ***, P 
 0.001. (B) Frozen sections of the brains were stained with anti-CD3 (top row) or isotype control MAbs (bottom row) (see
Materials and Methods). The arrows indicate representatives of CD3 T cells. The error bars indicate standard errors.
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mice could be due to the presence of low numbers of thymus-
independent T cells (Fig. 3B) only in the former animals. These
results from both SCID and nude mice strongly suggest that re-
cruitment of immune T cells mediated by VCAM-1/41 integrin
interaction is critical for inducing IFN--mediated protective im-
mune responses against T. gondii in the brain during the early
stage of reactivation of infection with T. gondii.
Importance of 4 integrin for prevention of proliferation of
tachyzoites in the brain during reactivation of T. gondii infec-
tion. We next examined whether the inhibition of induction of T
cell-dependent, IFN--mediated protective immune responses in
the brain by anti-4 integrin MAb assists in proliferation of
tachyzoites during reactivation of cerebral infection with T. gon-
dii. For this purpose, we examined the amounts of mRNA for
tachyzoite-specific SAG1 in the brains of infected nude mice 6
days after discontinuation of sulfadiazine treatment. Nude rather
than SCID mice were used in this experiment because the former
have B cells and we are able to examine the mechanisms of T cell
recruitment into the brain to prevent tachyzoite growth in the
presence of B cells. The amounts of SAG1 mRNA detected in the
brains of nude mice that had received immune T cells along with
treatment with anti-4 integrin MAb were 17 times greater than
those detected in the brains of animals that had received the T cells
with control MAb (P 
 0.01) (Fig. 6A). The amounts of SAG1
mRNA in the former were 15 times less than those detected in the
brains of animals that did not receive T cells (P 
 0.001) (Fig. 6A).
These results indicate that T cell recruitment mediated by binding
of lymphocyte 41 integrin to endothelial VCAM-1 is critical for
preventing tachyzoite growth during reactivation of chronic in-
fection with T. gondii in the brain, although T cell migration not
mediated by the VCAM-1/41 integrin interaction is also able to
partially inhibit tachyzoite proliferation.
In reactivation of chronic T. gondii infection, tachyzoite pro-
liferation occurs after the rupture of cysts, followed by invasion of
host cells by released bradyzoites and conversion of bradyzoites to
tachyzoites. Therefore, taking the ratios of mRNA levels for
tachyzoite-specific SAG1 to those for bradyzoite (cyst)-specific
BAG1 in the brain can be a useful indicator of the occurrence of
reactivation of the infection. In the brains of control mice that did
not receive T cells, almost equal amounts of mRNAs for
tachyzoite-specific SAG1 and bradyzoite-specific BAG1 were de-
tected (Fig. 6B), indicating the occurrence of reactivation of
chronic T. gondii infection. The SAG1/BAG1 mRNA ratios in the
brains of nude mice that had received immune T cells with treat-
ment with control MAb were markedly (7.5 times) less than those
of the control animals without the T cell transfer (Fig. 6B) (P 

0.05), demonstrating that the reactivation of cerebral T. gondii
infection was efficiently inhibited in the former animals. In con-
FIG 3 mRNA levels for T cell markers (CD3	, CD4, and CD8) (A) and numbers of CD4 and CD8 T cells (B) are markedly lower during the early stage
of reactivation of T. gondii infection in the brains of nude mice that received immune T cells with anti-4 integrin MAb treatment than in those with the cell
transfer with control MAb. Nude mice were infected with 10 cysts of the ME49 strain orally and treated with sulfadiazine for 3 weeks beginning 7 days after
infection. Groups of animals received immune T cells (0.9  107 cells) pretreated with either anti-4 integrin or a control MAb intravenously 4 weeks after
infection. Thereafter, the mice received the MAb (200 or 250 g) intraperitoneally every other day. Sulfadiazine treatment was discontinued 3 days after the cell
transfer, and mRNA levels for the T cell markers and numbers of CD4 and CD8 T cells in the brains were determined by real-time RT-PCR and flow cytometry
3 days after discontinuation of sulfadiazine treatment (see Materials and Methods). *, P 
 0.05; **, P 
 0.01; ***, P 
 0.001. The error bars indicate standard
errors.
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trast, the SAG1/BAG1 mRNA ratios in the brains of mice that had
received immune T cells with treatment with anti-4 integrin
MAb were equivalent to those of the control animals without the T
cell transfer (Fig. 6B). These results support the importance of T
cell recruitment mediated by binding of lymphocyte 41 integ-
rin to endothelial VCAM-1 for preventing reactivation of chronic
T. gondii infection and cerebral tachyzoite growth.
When BAG1 mRNA levels in the brain were compared be-
tween the groups of nude mice, animals treated with anti-4 in-
tegrin MAb had 53% greater amounts of the mRNA than those
treated with control MAb (Fig. 6C). Because the former had 17
times greater levels of SAG1 mRNA than the latter, a small portion
of tachyzoites proliferating in the brains of the former appear to
have converted to bradyzoites to form new cysts.
We performed immunohistochemistry detecting T. gondii to fur-
ther confirm the importance of VCAM-1/41 integrin interac-
tions for T cell recruitment into the brain to prevent reactivation
of T. gondii infection. The numbers of foci associated with
tachyzoites were 11 to 16 times less in the brains of nude mice that
had received immune T cells with treatment with control MAb
than in those of the animals that had received the T cells with
treatment with anti-4 integrin MAb and animals without the
cell transfer (Fig. 6D) (P 
 0.01 and P 
 0.001, respectively). In
addition, most of the foci associated with tachyzoites in the ani-
mals treated with control MAb contained only small numbers of
tachyzoites, and such tachyzoites were associated with large num-
bers of inflammatory cells infiltrated into the areas (Fig. 6F). In
contrast, those foci in the brains of animals treated with anti-4
integrin MAb contained large numbers of tachyzoites, but only
small numbers of inflammatory cells were detected in most of
those areas (Fig. 6G). Such inflammatory foci in these animals
were often associated with necrosis of brain tissue, as seen in Fig.
6G. In addition, the numbers of parasitophorous vacuoles con-
taining tachyzoites detected in the brain sections were 20 times
FIG 4 Expression of high levels of 41 integrin on the CD44high population of CD4 and CD8 splenic immune T cells in BALB/c mice chronically infected
with T. gondii. BALB/c mice were infected with 10 cysts of the ME49 strain orally, and their spleen cells were obtained during the chronic stage of infection for
analysis of expression of CD44, 4 integrin, and 1 integrin on CD4 and CD8 T cells by flow cytometry (see Materials and Methods). Arrows in the top row
indicate the upper right quadrant of the plots for 41 integrin and 41 integrinhigh populations.
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fewer in the brains of mice treated with control MAb than in those
of the animals treated with anti-4 integrin MAb (Fig. 6E) (P 

0.05). These observations strongly suggest that the VCAM-1/
41 integrin interaction is important for recruiting immune T
cells that can infiltrate the areas where tachyzoites started prolif-
erating to prevent reactivation of chronic cerebral infection with
T. gondii.
The amounts of mRNA for T cell markers (CD3	, CD4, and
CD8) were 46%, 47%, and 30% less in the nude mice with T cell
transfer in combination with anti-4 integrin MAb than in those
treated with control MAb (P 
 0.01, P 
 0.001, and P 
 0.05)
(Fig. 7) 6 days after discontinuation of sulfadiazine. The former
had markedly larger numbers of inflammatory foci associated
with tachyzoites than the latter, as shown in Fig. 6D. Therefore,
these results suggest that fewer T cells are associated with each of
these inflammatory foci to prevent tachyzoite growth in the brains
of mice treated with anti-4 integrin MAb than in those treated
with control MAb. Immunohistochemistry detecting T. gondii
eventually demonstrated the presence of fewer inflammatory cells
in the areas of foci associated with tachyzoites in the former than
the latter (Fig. 6F and G), as described above. The differences in
mRNAs for the T cell markers between these two groups were less
than those observed at 3 days after discontinuation of sulfadiazine
treatment (Fig. 3A). These results support the possibility that T
cells can infiltrate into the brain through a mechanism(s) not me-
diated by 4 integrin during the later stage of reactivation of the
infection. Local proliferation of T cells in the brain may also have
contributed, in part, to the smaller differences in the amounts of
mRNAs for these T cell markers between the two groups of mice.
In contrast to 3 days after discontinuation of sulfadiazine, the
amounts of mRNA for IFN- and NOS2 were 40% and 56%
greater in the brains of nude mice treated with anti-4 integrin
MAb than in those of animals treated with control MAb at the
later stage of reactivation of T. gondii infection (P 
 0.05 only for
NOS2) (Fig. 8). Such upregulated expression of these molecules in
anti-4 integrin MAb-treated animals could be due to the pres-
ence of greater stimulation of both innate immune cells and T cells
by markedly increased numbers of tachyzoites in the brains of
these animals, as shown in Fig. 6A. The capability of innate im-
mune cells to express upregulated IFN- and NOS2 in response to
increased numbers of tachyzoites is obvious from the evidence of
the presence of large amounts of mRNA for these molecules in the
brains of control animals that received no T cells (Fig. 8), and it is
consistent with our previous observations on production of IFN-
FIG 5 IFN- and NOS2 expression is markedly suppressed during the early stage of reactivation of T. gondii infection in the brains of SCID (A) and nude (B)
mice that received immune T cells with anti-4 integrin MAb treatment compared to animals with the cell transfer with control MAb. Mice were infected, treated
with sulfadiazine, and received T cells with treatment with anti-4 integrin or a control MAb as described in the legends to Fig. 2 and 3. Sulfadiazine treatment
was discontinued 3 days after the cell transfer, and mRNA levels for IFN- and NOS2 were determined by real-time RT-PCR 3 days after discontinuation of
sulfadiazine treatment (see Materials and Methods). *, P 
 0.05; **, P 
 0.01. The error bars indicate standard errors.
Sa et al.
2834 iai.asm.org Infection and Immunity
 on D
ecem
ber 7, 2015 by U
N
IV
 O
F
 K
E
N
T
U
C
K
Y
http://iai.asm
.org/
D
ow
nloaded from
 
by NK cells, microglia, and macrophages during reactivation of
the infection (41). In addition, the animals that had received im-
mune T cells with anti-4 integrin MAb treatment had suppressed
but still significant T cell infiltration into their brains at the later
stage of reactivation of the infection, as described above and
shown in Fig. 7. Those T cells in the presence of large numbers of
tachyzoites could certainly contribute to the upregulated IFN-
responses and induction of NOS2, most likely by microglia (42),
in these animals. However, it is apparent that the upregulated
expression of IFN- and NOS2 in the anti-4 integrin MAb-
treated mice in this later stage of reactivation of infection is not
efficient in controlling the parasite, because large numbers of foci
associated with tachyzoites and large amounts of tachyzoite-spe-
cific SAG1 mRNA were present in their brains (Fig. 6A and D). In
addition, brain tissue necrosis had already developed in many of
the areas of inflammatory foci associated with tachyzoites in these
mice by this later stage of reactivation of infection, as shown in Fig.
6G. It appears that induction of increased expression of IFN- and
NOS2 after large numbers of tachyzoites had already grown is not
effective in controlling the parasite in the brain. These results
strongly suggest that prompt recruitment of immune T cells me-
diated by VCAM-1/41 integrin interaction to induce IFN--
FIG 6 (A to C) Greater levels of tachyzoite-specific SAG1 (A) and bradyzoite-specific BAG1 (C) mRNAs and higher ratios of the SAG1 mRNA level to the BAG1
mRNA level (B) are detected during the later stage of reactivation of T. gondii infection in the brains of nude mice that had received immune T cells with anti-4
integrin MAb treatment than in animals that had received the T cells with a control MAb. (D and E) Greater numbers of foci associated with tachyzoites (D) and
PV containing tachyzoites (E) are also detected in the brains of the former than of the latter. Mice were infected, treated with sulfadiazine, and received T cells
(1.5  107 cells) with treatment with anti-4 integrin or a control MAb as described in the legend to Fig. 3. Sulfadiazine treatment was discontinued 3 days after
the cell transfer, and mRNA levels for SAG1 and BAG1 and numbers of tachyzoite-associated foci and PV were determined 6 days after discontinuation of
sulfadiazine treatment (see Materials and Methods). *, P 
 0.05; **, P 
 0.01; ***, P 
 0.001. The error bars indicate standard errors. (F and G) Representative
inflammatory foci associated with tachyzoites in the brains of mice treated with control MAb (F) or anti-4 integrin MAb (G). The sections were conterstained
with hematoxylin to visualize the nuclei of the host cells. The arrows indicate representative PV containing tachyzoites.
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mediated protective immune responses during the early stage of
reactivation of infection is crucial for preventing proliferation of
tachyzoites in the brain and TE, although T cells can infiltrate into
the brain in an 4 integrin-independent manner during the later
stage of infection.
DISCUSSION
T cells and IFN--mediated immune responses are essential for
prevention of reactivation of cerebral infection with T. gondii (20,
22, 23). In the present study, we utilized a murine model of reac-
tivation of chronic infection with the parasite and examined the
adhesion molecules important for recruiting immune T cells into
the brain to prevent reactivation of the cerebral infection. In this
animal model, infected, sulfadiazine-treated SCID and nude mice
received a systemic transfer of immune T cells, and reactivation of
cerebral T. gondii infection was initiated by discontinuation of
sulfadiazine treatment (20, 22, 23). Immunohistochemical study
revealed that VCAM-1 and ICAM-1 are the two cerebrovascular
endothelial adhesion molecules expressed in both wild-type and
SCID mice during the chronic stage of infection. Although the
cerebrovascular VCAM-1 expression following the infection is
largely dependent on IFN- (33), microglia in SCID and nude
mice and NK cells are able to produce this cytokine in response to
T. gondii (41, 43, 44). IFN- production by these non-T cells ap-
pears to be sufficient to upregulate VCAM-1 expression on the
cerebral vessels in infected SCID and nude mice. Therefore, the
infected SCID and nude mice provided a suitable model to analyze
the adhesion molecules important for recruiting the T cells into
the brain to maintain the latency of chronic infection with T.
gondii in the brain.
In the present study, we utilized inhibition of binding of lym-
phocyte 41 integrin to endothelial VCAM-1 on cerebral vessels
by anti-4 integrin MAb to analyze the role of interactions be-
tween these adhesion molecules in T cell recruitment and preven-
tion of reactivation of chronic T. gondii infection in the brains of
infected SCID and nude mice that received a systemic transfer of
immune T cells. Flow cytometric analyses demonstrated that the
numbers of CD4 and CD8 immune T cells that had migrated
into the brain within 3 days after the initiation of reactivation of
the cerebral infection were significantly lower in nude mice
treated with anti-4 integrin MAb than in animals treated with
control MAb. These observations were consistent with the detec-
FIG 7 mRNA levels for T cell markers (CD3	, CD4, and CD8) are lower during the later stage of reactivation of T. gondii infection in the brains of nude mice
that received immune T cells with anti-4 integrin MAb treatment than in those with the cell transfer with control MAb. Mice were infected, treated with
sulfadiazine, and received T cells with treatment with anti-4 integrin or a control MAb as described in the legend to Fig. 5. mRNA levels for the T cell markers
were measured by real-time RT-PCR 6 days after discontinuation of sulfadiazine treatment (see Materials and Methods). *, P 
 0.05; **, P 
 0.01; ***, P 
 0.001.
The error bars indicate standard errors.
FIG 8 IFN- and NOS2 expression is increased during the later stage of reactivation of T. gondii infection in the brains of nude mice that received immune T cells
with anti-4 integrin MAb compared to animals with the cell transfer with control MAb. Mice were infected, treated with sulfadiazine, and received T cells with
treatment with anti-4 integrin or a control MAb as described in the legend to Fig. 5. mRNA levels for IFN- and NOS2 were measured by real-time RT-PCR 6
days after discontinuation of sulfadiazine treatment (see Materials and Methods). *, P 
 0.05. The error bars indicate standard errors.
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tion of markedly smaller amounts of mRNA for the T cell markers
CD3	, CD4, and CD8 in the brains of SCID and nude mice
treated with anti-4 integrin MAb than in those treated with con-
trol MAb at this early stage of reactivation of infection. Immuno-
histochemical studies also demonstrated the presence of large
numbers of CD3 T cells in the brain parenchyma of the SCID
mice treated with control MAb, but not in the animals treated with
anti-4 integrin MAb. These results indicate that VCAM-1/41
integrin interaction is crucial for recruitment of both CD4 and
CD8 immune T cells into the brain during the early stage of
reactivation of infection with T. gondii.
Our previous study showed that treatment of mice with the
anti-4 integrin MAb does not affect homing of systemically
transferred lymphocytes labeled with tetramethyl rhodamine iso-
cyanate (TRITC) to the spleen or peripheral lymph nodes but
reduces their homing to bronchus- and gut-associated lymphoid
tissues in short-term lymphocyte-homing assays (28). The block-
ing effects of the MAb resulted in increased numbers of the labeled
lymphocytes present in the peripheral blood. Therefore, anti-4
integrin would not have reduced the numbers of T cells in the
peripheral blood available to infiltrate into the brain in the present
study. Therefore, the effect of anti-4 integrin MAb observed in
the present study is the inhibition of recruitment of immune T
cells from the periphery into the brain during reactivation of in-
fection with T. gondii.
IFN- is essential to maintain the latency of chronic infection
with T. gondii in the brain and to prevent TE (4, 20, 45). In vitro
studies showed that IFN- activates microglia to prevent
tachyzoite growth (46, 47), and the antimicrobial activity of the
murine microglia is mediated by production of nitric oxide by
NOS2 (42). Murine models also previously demonstrated the im-
portance of NOS2 in controlling the parasite in the brain during
the later stage of infection (39, 40). The present study demon-
strated that 3 days after discontinuation of sulfadiazine treatment,
IFN- and NOS2 mRNA levels were 3 to 9 times lower in the
brains of SCID and nude mice that had received immune T cells
with anti-4 integrin MAb than in those that had received the T
cells with control MAb. Since the expression levels of these two
molecules in the brains of control mice that had received no T cells
were equivalent to or lower than those in animals with T cell
transfer in combination with anti-4 integrin MAb, the impaired
production of IFN- by T cells is most likely the major cause of the
suppressed NOS2 expression in animals treated with anti-4 in-
tegrin MAb. Therefore, VCAM-1/41 integrin interaction is
critical for promptly recruiting immune T cells capable of produc-
ing IFN- into the brain and inducing expression of NOS2 during
the early stage of reactivation of cerebral T. gondii infection. To
our knowledge, the present study provides the first evidence indi-
cating the importance of VCAM-1/41 integrin interaction for
inducing IFN--dependent protective immune responses against
T. gondii in the brain.
At a later stage of reactivation of cerebral T. gondii infection (6
days after discontinuation of sulfadiazine treatment), 17 times
greater amounts of mRNA for tachyzoite-specific SAG1 were de-
tected in the brains of nude mice that had received immune T cells
with anti-4 integrin MAb than in animals that had received the
cells with control MAb. The presence of large amounts of SAG1
mRNA in the former was associated with high SAG1/BAG1
mRNA ratios, indicating the occurrence of reactivation of ce-
rebral T. gondii infection in these animals. In contrast, SAG1/
BAG1 mRNA ratios remained low in the animals treated with
control MAb. This is consistent with the presence of markedly
greater numbers of foci associated with tachyzoites and greater
numbers of parasitophorous vacuoles containing tachyzoites in
the sections of the brains of mice treated with anti-4 integrin
MAb than in animals that had received the cells with control MAb.
Thus, T cell recruitment into the brain through VCAM-1/41
integrin interaction is crucial to effectively inhibit reactivation of
chronic T. gondii infection and prevent cerebral tachyzoite
growth.
Interestingly, there was more cerebral mRNA for IFN- and
NOS2 in the animals treated with anti-4 integrin MAb than in
animals treated with control MAb at the later stage of reactivation
of infection, probably due to greater stimulation of innate im-
mune cells and T cells by large numbers of tachyzoites in the
brains of the former animals. However, such upregulated expres-
sion of IFN- and NOS2 in the anti-4 integrin MAb-treated mice
does not seem to prevent pathological effects of tachyzoite growth,
because inflammatory foci associated with large numbers of
tachyzoites and tissue necrosis in the brain have already developed
by this stage of reactivation of infection. Thus, it is most likely that
quick recruitment of immune T cells mediated by VCAM-1/41
integrin interaction into the brain and prompt induction of cere-
bral expression of IFN- and NOS2 during the early stage of reac-
tivation of T. gondii infection are crucial for successful control of
the parasite and prevention of TE. To our knowledge, the impor-
tance of T cell recruitment mediated by VCAM-1/41 integrin
interaction for prevention of reactivation of chronic T. gondii in-
fection by induction of IFN--dependent protective immunity
has not been reported before.
The present study used BALB/c-background SCID and nude
mice infected with a type II strain of T. gondii as a model of reac-
tivation of chronic T. gondii infection. In contrast to BALB/c mice,
which are genetically resistant to the infection and maintain the
latency of chronic infection, C57BL/6 mice are genetically suscep-
tible to the infection and develop progressive and ultimately fatal
TE during the later stage of the infection. A previous study using
C57BL/6 mice infected with a T. gondii strain genetically modified
to secrete ovalbumin (OVA) and a transfer of OVA-specific T cell
receptor transgenic mouse (OT-1) CD8 T cells activated with
OVA in vitro showed that 41 integrin is important for recruit-
ment of the OVA-specific OT-1 CD8 T cells into the brains of the
animals and for suppressing parasite DNA levels during progres-
sive TE (48). Another study using a susceptible strain of mice
showed that neonatal inactivation of the VCAM-1 gene did not
impair leukocyte recruitment into the brain after T. gondii infec-
tion (49). The reasons for the differences in the observations in
these two studies in TE-susceptible strains of mice are unclear. It is
possible that neonatal inactivation of VCAM-1 had resulted in
expression of a molecule that is not usually expressed in wild-type
mice to compensate for the absence of VCAM-1. It is also possible
that T. gondii infection induces the expression of multiple adhe-
sion molecules, including 41 integrin, in wild-type C57BL/6
mice and that these adhesion molecules have redundant roles in
recruiting the T cells into the brains of infected animals, whereas
adhesion molecules expressed on the OT-1 CD8 T cells activated
with OVA in vitro are limited to 41 integrin.
The present study demonstrated the importance of VCAM-1/
41 integrin interaction for recruitment of immune T cells into
the brain to prevent reactivation of chronic cerebral infection with
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T. gondii. The importance of VCAM-1/41 integrin interactions
in recruitment of T cells has also been reported in cerebral infec-
tions with coronavirus and Listeria monocytogenes (50, 51),
whereas the involvement of ICAM-1 was shown in T cell recruit-
ment into the brain during infections with Sinbis and Theiler’s
viruses (52, 53). Therefore, it is important to elucidate the patho-
gen-specific mechanisms of T cell recruitment into the brain for
controlling different infections. In the present study, we showed
that treatment of T. gondii-infected mice with anti-4 integrin
MAb markedly inhibited recruitment of CD4 and CD8 im-
mune T cells into their brains and induction of IFN--dependent
protective immune responses to prevent reactivation of cerebral
infection with the parasite. Anti-4 integrin humanized MAb (na-
talizumab) has been used for treatment of two diseases, multiple
sclerosis and Crohn’s disease (54, 55). Since 500 million to 2 bil-
lion people are estimated to be chronically infected with T. gondii
worldwide, it is possible that individuals with chronic infection
with the parasite will receive the anti-4 integrin MAb for treat-
ment of multiple sclerosis or Crohn’s disease. It is possible that the
anti-4 integrin MAb intended to treat these diseases causes reac-
tivation of T. gondii infection in the brains of the patients who
have been chronically infected with the parasite. Although the
occurrence of ocular toxoplasmosis during treatment of multiple
sclerosis with natalizumab has recently been reported (56), occur-
rence of cerebral toxoplasmosis associated with the treatment has
not been reported yet. It may be important to consider the possi-
ble occurrence of reactivation of cerebral T. gondii infection as a
side effect of treatment with anti-4 integrin MAb in patients with
multiple sclerosis or Crohn’s disease.
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